Apheresis Devices Market Size, Share and Growth Outlook, 2026

Apheresis Devices Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Apheresis Devices Market size is forecast to increase from $3.93 Billion in 2026 to $8.06 Billion in 2034 at a CAGR of 9.4% between 2026 and 2034.

The Apheresis Devices market report provides detailed analysis and outlook of Apheresis Devices segments including By Product Type (Apheresis Devices, Apheresis Consumables ), By Technology (Centrifugation, Membrane Filtration), By Procedure Type (Plasmapheresis, Photopheresis, Erythrocytapheresis, Leukapheresis, Plateletpheresis, LDL Apheresis), By Application (Neurological Disorders, Hematological Disorders, Renal Disorders, Autoimmune Disorders, Cardiovascular Disorders), By End User (Hospitals and Clinics, Blood Donation Centers, Ambulatory Surgical Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Apheresis Devices Industry Overview

Automation and Personalized Collection Technologies Transforming Apheresis Operations

The apheresis devices industry is increasingly focused on automation, donor optimization, and operational efficiency to improve collection outcomes across plasma donation and therapeutic apheresis settings. A major development is the successful nationwide deployment of Adaptive Nomogram technology with the Aurora Xi Plasmapheresis System by Fresenius Kabi. The technology customizes plasma collection volumes according to individual donor characteristics, enabling more precise and efficient plasma harvesting. Personalized collection strategies are gaining traction as plasma demand continues to increase globally, encouraging operators to maximize collection performance while maintaining donor safety and comfort. These advancements are supporting higher operational productivity and strengthening plasma supply chain reliability.

Digital Integration Enhancing Plasma Collection Efficiency

Digitalization and data-driven donor management are becoming central themes within the apheresis devices market. Haemonetics continues expanding its Persona® Technology across the NexSys PCS platform, supported by clinical evidence demonstrating a 9% to 12% increase in plasma yield per donation. The technology leverages donor-specific data to optimize collection procedures and improve overall efficiency. In addition, integration with the NexLynk DMS® donor management platform enables real-time automated reporting and streamlined operational oversight. These capabilities allow plasma collection centers to monitor performance metrics continuously, improve workflow management, and enhance donor engagement. As collection facilities seek greater scalability and operational consistency, connected apheresis platforms are emerging as critical tools for modern plasma procurement strategies.

Cell Therapy Manufacturing Creating New Growth Opportunities

The expanding cell and gene therapy sector is creating additional demand for advanced apheresis technologies capable of supporting complex biologics manufacturing workflows. Terumo BCT and Steminent Biotherapeutics entered a strategic collaboration focused on late-stage mesenchymal stem cell therapy production. The partnership utilizes Terumo’s Quantum Flex™ Automated Cell Expansion System to create a highly automated workflow extending from apheresis collection through cell expansion for clinical trial applications. This trend reflects the growing convergence of apheresis technology and regenerative medicine manufacturing. At the same time, evolving reimbursement frameworks continue to influence industry adoption, with the Centers for Medicare & Medicaid Services proposing updated outpatient payment rates for apheresis procedures under the CY 2026 OPPS framework. Together, automation, digital integration, and cell therapy applications are expanding the clinical and commercial significance of advanced apheresis systems.

Apheresis Devices Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Apheresis Devices market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Terumo Corporation , Fresenius SE & Co. KGaA , Haemonetics Corporation, Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Nikkiso Co., Ltd., Macopharma SA, Miltenyi Biotec B.V. & Co. KG, Kaneka Corporation, Mallinckrodt plc. The Apheresis Devices market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Apheresis Devices industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Apheresis Devices Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Apheresis Devices companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Apheresis Devices markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Apheresis Devices Market Competitive Benchmarking and Company Analysis

Leading companies in Apheresis Devices industry include- Terumo Corporation , Fresenius SE & Co. KGaA , Haemonetics Corporation, Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Nikkiso Co., Ltd., Macopharma SA, Miltenyi Biotec B.V. & Co. KG, Kaneka Corporation, Mallinckrodt plc. The Apheresis Devices market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Apheresis Devices Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Apheresis Devices market remains one of the strongest-performing segments in the country.
The US Apheresis Devices Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Apheresis Devices market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Apheresis Devices industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Apheresis Devices markets

Canada's strong Apheresis Devices sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Apheresis Devices market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Apheresis Devices Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Apheresis Devices market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Apheresis Devices population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Apheresis Devices industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Apheresis Devices market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Apheresis Devices sales through 2034

France Apheresis Devices companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Apheresis Devices Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Apheresis Devices distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Apheresis Devices Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Apheresis Devices market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Apheresis Devices industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Apheresis Devices industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Apheresis Devices Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Apheresis Devices market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Apheresis Devices market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Apheresis Devices Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Apheresis Devices Market Segmentation

By Product Type
Apheresis Devices
Apheresis Consumables
By Technology
Centrifugation
Membrane Filtration
By Procedure Type
Plasmapheresis
Photopheresis
Erythrocytapheresis
Leukapheresis
Plateletpheresis
LDL Apheresis
By Application
Neurological Disorders
Hematological Disorders
Renal Disorders
Autoimmune Disorders
Cardiovascular Disorders
By End User
Hospitals and Clinics
Blood Donation Centers
Ambulatory Surgical Centers

Top Companies in Apheresis Devices Industry

Terumo Corporation
Fresenius SE & Co. KGaA
Haemonetics Corporation
Asahi Kasei Medical Co., Ltd.
B. Braun Melsungen AG
Nikkiso Co., Ltd.
Macopharma SA
Miltenyi Biotec B.V. & Co. KG
Kaneka Corporation
Mallinckrodt plc

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025